Zobrazeno 1 - 10
of 275
pro vyhledávání: '"Enterogastrone"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Diabetes Investigation
The present review focuses initially on experimental studies that were designed to identify acid inhibitory factors, referred to as ‘enterogastrones,’ that ultimately led to the isolation of gastric inhibitory polypeptide (GIP), a 42‐amino acid
Autor:
Marcel H. A. Muskiet, Daniël H. van Raalte, Lennart Tonneijck, Djuna L. Cahen, Mark H. H. Kramer, Mark M. Smits
Publikováno v:
Smits, M M, van Raalte, D H, Tonneijck, L, Muskiet, M H A, Kramer, M H H & Cahen, D L 2016, ' GLP-1 based therapies : clinical implications for gastroenterologists ', Gut, vol. 65, no. 4, pp. 702-11 . https://doi.org/10.1136/gutjnl-2015-310572
Gut, 65(4), 702-711. BMJ Publishing Group
Gut, 65(4), 702-11. BMJ Publishing Group
Gut, 65(4), 702-711. BMJ Publishing Group
Gut, 65(4), 702-11. BMJ Publishing Group
The gut-derived incretin hormone, glucagon-like peptide 1 (GLP-1) lowers postprandial blood glucose levels by stimulating insulin and inhibiting glucagon secretion. Two novel antihyperglycaemic drug classes augment these effects; GLP-1 receptor agoni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bd7624898742a258352e0c23ff93ce7
https://research.vumc.nl/en/publications/030bc188-0f3c-486b-b750-c0384a8ec6be
https://research.vumc.nl/en/publications/030bc188-0f3c-486b-b750-c0384a8ec6be
Autor:
Jörg Schirra, Burkhard Göke
Publikováno v:
Regulatory Peptides. 128:109-115
The proglucagon-derived peptide glucagon-like peptide-1 (GLP-1) is an intestinal signal peptide postprandially released from the L cells of the lower gut. Exogenously administered the synthetic hormone exerts a glucose-dependent insulinotropic effect
Autor:
Jens J. Holst, Jose A. L. Calbet
Publikováno v:
European Journal of Nutrition. 43:127-139
The influence of protein fractionation on gastric emptying and rate of appearance of their constituent amino acids in peripheral blood remains unknown.To examine the influence of the degree of protein fractionation on gastric emptying, gastric secret
Publikováno v:
American Journal of Physiology-Gastrointestinal and Liver Physiology. 279:G561-G566
Glucose-dependent insulinotropic polypeptide (GIP) release has been demonstrated predominantly after ingestion of carbohydrate and fat. These studies were conducted to determine the effects of protein on GIP expression in the rat. Whereas no signific
Publikováno v:
American Journal of Physiology-Gastrointestinal and Liver Physiology. 276:G550-G555
Fat in small intestine decreases meal-stimulated gastric acid secretion and slows gastric emptying. CCK is a mediator of this inhibitory effect (an enterogastrone). Because intravenously administered peptide YY (PYY) inhibits acid secretion, endogeno
Publikováno v:
Digestive Diseases and Sciences. 43:1133-1140
Glucagon-like polypeptide 1 (GLP-1) may be amajor enterogastrone, slowing gastric emptying whenreleased by intestinal nutrients. In six conscious dogs,we studied the effects of GLP-1, on antropyloric motility, gastric emptying, and transpyloricflow a
Autor:
Jens F. Rehfeld, Berit Sternby, Jens J. Holst, Steen Larsen, André Wettergren, Morten Wojdemann, Ole Olsen
Publikováno v:
Digestive Diseases and Sciences. 43:799-805
Glucagon-like peptide-1 (GLP-1) may be one of the enterogastrone hormones of the ileal brake mechanism. We therefore studied its effects on gastric lipase secretion in healthy volunteers and vagotomized patients during infusion of pentagastrin. The i
Publikováno v:
Neurogastroenterology and Motility. 9:109-116
The pancreatic polypeptide family of hormones and neurotransmitters including pancreatic polypeptide (PP), peptide YY (PYY) and neuropeptide Y (NPY) are emerging as potent central regulators of gastric function. There is, however, considerable debate